Skip to main navigation
Skip to search
Skip to main content
UT MD Anderson Cancer Center Home
Help & FAQ
Link opens in a new tab
Search content at UT MD Anderson Cancer Center
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Central nervous system gangliogliomas. Part 2: Clinical outcome
F. F. Lang
, F. J. Epstein
, J. Ransohoff
, J. C. Allen
, J. Wisoff
, I. R. Abbott
, D. C. Miller
Research output
:
Contribution to journal
›
Article
›
peer-review
269
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Central nervous system gangliogliomas. Part 2: Clinical outcome'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Clinical Outcomes
100%
Central Nervous System
100%
Ganglioglioma
100%
Spinal Cord
45%
Brainstem
45%
Cerebral Hemispheres
45%
Histological Grade
27%
Survival Rate
27%
Event-free Survival
27%
Long-term Survival
18%
Gross Total Resection
18%
Tumor
9%
Follow-up Examination
9%
Patient Survival
9%
Postoperative Morbidity
9%
Adjuvant Therapy
9%
Functional Outcome
9%
Multivariate Analysis
9%
Tumor Location
9%
Survival Outcomes
9%
Recurrence Rate
9%
Surgery Alone
9%
Radical Resection
9%
Recurrence Risk
9%
Relative Risk
9%
Morbidity Rate
9%
Radical Surgery
9%
Actuarial Survival
9%
Operative
9%
High-grade Tumor
9%
Linear Regression
9%
Neurological Function
9%
Grade Two
9%
Survival Event
9%
Surgically Treated
9%
Postoperative Chemotherapy
9%
Postoperative Irradiation
9%
Medicine and Dentistry
Ganglioglioma
100%
Central Nervous System
100%
Brainstem
45%
Cerebral Hemisphere
45%
Spinal Cord
45%
Survival Rate
27%
Event Free Survival
27%
Recurrent Disease
18%
Long Term Survival
18%
Tumor
18%
Neoplasm
9%
Adjuvant Therapy
9%
Proportional Hazards Model
9%
Chemotherapy
9%
Radical Resection
9%
Radical Surgery
9%
Linear Regression Analysis
9%
Nervous System Physiology
9%
Median Follow Up
9%
Neuroscience
Central Nervous System
100%
Brainstem
100%
Spinal Cord
100%
Chemotherapy
20%
Adjuvant Therapy
20%